Lataa...
PRC2 engages a bivalent H3K27M-H3K27me3 dinucleosome inhibitor
A lysine-to-methionine mutation at lysine 27 of histone 3 (H3K27M) has been shown to promote oncogenesis in a subset of pediatric gliomas. While there is evidence that this “oncohistone” mutation acts by inhibiting the histone methyltransferase PRC2, the details of this proposed mechanism neverthele...
Tallennettuna:
| Julkaisussa: | Proc Natl Acad Sci U S A |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
National Academy of Sciences
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825254/ https://ncbi.nlm.nih.gov/pubmed/31611394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1911775116 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|